SCN Blog

CoinAgenda Summit Main Conference CoinAgenda Summit is the largest CoinAgenda to date, with more than 25,000 sq feet at Caesar’s Palace to hold 1,000 attendees, 40 speakers/presenters and [...]

ATLANTIC CITY — A private equity firm in New York City has put a $220 million offer on the table to buy the former Revel casino, which has been renamed TEN, according to a report. [...]

By Pablo Erbar Craig Kaufman, CEO of IdeaGeneration Group, and Jeff Dorman, COO of Harvest Exchange, came together last month to announce the creation of Hedge Fund Nation, a new entity within [...]

By Jutta Schulze Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) and GE Healthcare Life Sciences China (GE Healthcare) announced a month ago that they have committed to a research cooperation [...]

By Jutta Schulze Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on research and development in the area of innovative drug delivery technology. Their current stronghold is a [...]

By Ryan Austin Not everyone is impressed by the leaps and bounds made by tech companies in recent years. Where jobs are concerned, the exponential growth of technology is a double-edged sword. [...]

By Ryan Austin Marcum LLP will be hosting its highly anticipated Marcum MicroCap Conference at the Grand Hyatt Hotel in New York City on June 15th and 16th. Ahead of the event, SCN Corporate [...]

By Jutta Schulze Thomas Hallam Ph.D., CEO of Leading BioSciences, Inc., recently introduced the company’s lead drug LB1148, which is currently in the second phase of clinical trials. The focus of [...]

By Pablo Erbar Biostage Inc (NASDAQ:BSTG) recently made a potentially decisive move, announcing the promotion of Saverio La Francesca, M.D. from Chief Medical Officer to President. Considering [...]

By Pablo Erbar Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) recently entered a stock purchase agreement with a group of investors for the sale of $70 million worth of redeemable convertible [...]